Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

BACKGROUND: Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid (EPA) ethyl ester indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. ANCHOR was a 12-week, phase 3 study that evaluated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinton, Eliot A, Ballantyne, Christie M, Bays, Harold E, Kastelein, John J, Braeckman, Rene A, Soni, Paresh N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718763/
https://www.ncbi.nlm.nih.gov/pubmed/23835245
http://dx.doi.org/10.1186/1475-2840-12-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718763/
https://www.ncbi.nlm.nih.gov/pubmed/23835245
http://dx.doi.org/10.1186/1475-2840-12-100

Ejemplares similares